Grace Therapeutics director Opaleye Management buys $31,686 in stock By Investing.com - Investing.com India

Source: Investing.com India · 2026-09-24T00:21:38+00:00

Grace Therapeutics director Opaleye Management buys $31,686 in stock By Investing.com Investing.com India

BestAIBroker analysis

Finance-aware sentiment: slightly positive (+0.10 on a -1 to +1 scale).
Event classification: OTHER.
Market importance score: 31/100, weighting entity relevance, source credibility, multi-outlet coverage and recency.
Symbols referenced: GRCE, RMCOW, ARES, WM, RM.